Contribute Try STAT+ Today

Two of the lawmakers tasked with grilling pharmaceutical executives on the development of Covid-19 vaccines also own stock in one or more of the companies, creating potential conflicts of interest as drug manufacturers race toward lucrative scientific breakthroughs.

Reps. Joe Kennedy and Michael Burgess are members of the House subcommittee that will question officials from Pfizer, Merck, Johnson & Johnson, AstraZeneca, and Moderna on Tuesday. Each member holds shares in at least one of the companies. Kennedy, a Massachusetts Democrat, owns as much as $1.7 million of stock in three of them, according to his most recent financial disclosure.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.